SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-182726
Filing Date
2014-05-05
Accepted
2014-05-05 17:08:54
Documents
13
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d708649d10q.htm 10-Q 843881
2 EX-10.1 d708649dex101.htm EX-10.1 169957
3 EX-10.2 d708649dex102.htm EX-10.2 184536
4 EX-31.1 d708649dex311.htm EX-31.1 6730
5 EX-31.2 d708649dex312.htm EX-31.2 6743
6 EX-32.1 d708649dex321.htm EX-32.1 3739
7 EX-32.2 d708649dex322.htm EX-32.2 3732
  Complete submission text file 0001193125-14-182726.txt   9560492

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT act-20140331.xml EX-101.INS 1387433
9 XBRL TAXONOMY EXTENSION SCHEMA act-20140331.xsd EX-101.SCH 96899
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE act-20140331_cal.xml EX-101.CAL 115846
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE act-20140331_def.xml EX-101.DEF 350712
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE act-20140331_lab.xml EX-101.LAB 693682
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE act-20140331_pre.xml EX-101.PRE 545196
Mailing Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2
Business Address 70 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 2 (216) 523-5000
Actavis plc (Filer) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55075 | Film No.: 14814399
SIC: 2834 Pharmaceutical Preparations